US Senate Bill Aims To Increase Generic Competition

expensive drugs

US Senators Charles Grassley, Patrick Leahy, Mike Lee, and Amy Klobuchar introduced a bipartisan bill which could prevent big pharmaceutical firms from exploiting current rules and keeping generic competition out of the market. Grassley and Lee are Republicans, while Leahy and Klobuchar are Democrats. There has been concern that the risk evaluation and mitigation strategy (REMS) program was being misused to prevent generic companies from gaining access to a safety protocol needed to enter the market. The new legislation would allow generic companies to file a lawsuit forcing negotiations for access.

Read the source article at Raw Story

About the Author

Related Posts

Leave a Reply